Nature Medicine vs JAMA
Nature Medicine and JAMA are both elite medical journals, but Nature Medicine wants translational mechanism while JAMA wants broad clinical evidence.
Associate Professor, Clinical Medicine & Public Health
Author context
Specializes in clinical and epidemiological research publishing, with direct experience preparing manuscripts for NEJM, JAMA, BMJ, and The Lancet.
Journal fit
See whether this paper looks realistic for Nature Medicine.
Run the Free Readiness Scan with Nature Medicine as your target journal and see whether this paper looks like a realistic submission.
Nature Medicine at a glance
Key metrics to place the journal before deciding whether it fits your manuscript and career goals.
What makes this journal worth targeting
- IF 50.0 puts Nature Medicine in a visible tier — citations from papers here carry real weight.
- Scope specificity matters more than impact factor for most manuscript decisions.
- Acceptance rate of ~<8% means fit determines most outcomes.
When to look elsewhere
- When your paper sits at the edge of the journal's stated scope — borderline fit rarely improves after submission.
- If timeline matters: Nature Medicine takes ~~30 days. A faster-turnaround journal may suit a grant or job deadline better.
- If OA is required: gold OA costs ~$11,690 USD. Check institutional agreements before submitting.
Nature Medicine vs JAMA at a glance
Use the table to see where the journals diverge before you read the longer comparison. The right choice usually comes down to scope, editorial filter, and the kind of paper you actually have.
Question | Nature Medicine | JAMA |
|---|---|---|
Best fit | Nature Medicine published by Nature is one of the most selective medical research. | JAMA is one of the most widely read clinical journals in the world, with an impact. |
Editors prioritize | Medical advance with clear human health or clinical impact | Immediate clinical applicability |
Typical article types | Research Article | Original Investigation, Research Letter |
Closest alternatives | Cell, Science | NEJM, The Lancet |
Quick answer: Choose Nature Medicine when the manuscript's lead story is translational mechanism with convincing human relevance. Choose JAMA when the lead story is broad clinical evidence, patient-care relevance, health policy, or practice-facing medicine. The impact factors are close enough that fit matters more than the number.
If you want a fast journal-fit read before submission, start with the AI manuscript review. For journal-specific preparation, read the Nature Medicine submission guide and JAMA submission guide.
Method note: this page uses Nature Medicine aims and metrics, JAMA author materials, JCR metric references, and Manusights journal-fit review patterns reviewed in April 2026. This is the canonical comparison page; do not also build jama-vs-nature-medicine.Head-to-head comparison
Question | Nature Medicine | JAMA |
|---|---|---|
Core editorial question | Does this translate biology or technology into human health insight? | Does this matter to a broad clinical readership? |
Strongest paper | Mechanism plus human validation | Broad clinical, policy, diagnostic, or practice evidence |
2024 JIF signal | 50.0 reported by Nature Medicine | 55.0 commonly cited for JCR 2024 |
Best audience | Translational scientists and clinical researchers | Clinicians, clinical researchers, health systems readers |
Common fit mistake | Clinical data are decorative | Paper is too mechanistic or specialty-narrow |
Better first page | Mechanism-to-human bridge | Practice, patient, or health-system consequence |
These journals are close in prestige but different in editorial instinct.
Choose Nature Medicine If / Choose JAMA If
Choose Nature Medicine if the manuscript's first-page promise is translational. The reader should see a biological, technological, biomarker, or disease-mechanism story that becomes more convincing because it is tied to human health.
Choose JAMA if the first-page promise is clinical. The reader should see a question that matters across medicine, affects practice or interpretation, and can be understood without making mechanism the main event.
This is the cleanest way to avoid cannibalization between comparison pages. Nature Medicine vs JAMA is not a generic "top medical journal" page. It is a decision page for authors choosing between translational prestige and broad clinical reach.
Journal fit
Ready to find out which journal fits? Run the scan for Nature Medicine first.
Run the scan with Nature Medicine as the target. Get a fit signal that makes the comparison concrete.
The Simple Decision
If the paper explains why a disease process, therapy, technology, or biomarker matters in humans, Nature Medicine is usually the cleaner target.
If the paper tells clinicians, guideline writers, policy readers, or health-system researchers something they can act on or interpret broadly, JAMA is usually the cleaner target.
Manuscript lead story | Better first target |
|---|---|
Disease mechanism with human validation | Nature Medicine |
Randomized clinical study with broad practice relevance | JAMA |
Biomarker tied to translational biology | Nature Medicine |
Screening, diagnostic, population, or health-policy evidence | JAMA |
Early clinical trial with mechanism-rich companion data | Nature Medicine |
Clinical finding aimed mainly at one subspecialty | JAMA specialty journal or top specialty venue |
If the lead story is unclear, fix the abstract before choosing the journal.
What Nature Medicine Wants
Nature Medicine's aims and scope state that it considers translational and clinical research based on originality, timeliness, and impact on improving human health. It covers clinical trials, observational studies, meta-analyses, biomarker studies, public health studies, and hybrid studies that combine preclinical and clinical findings.
That breadth is not an invitation to send every clinical paper. Nature Medicine is strongest when the manuscript builds a bridge between mechanism and human health.
What JAMA Wants
JAMA positions itself around original, important, valid, peer-reviewed articles across medicine. In practice, it is strongest when the paper has broad clinical relevance, readable framing, strong reporting, and a clear reason for a general medical audience to care.
JAMA is often more natural than Nature Medicine when the manuscript's value is:
- clinical practice evidence
- population health
- health policy
- screening or diagnostic evidence
- outcomes research
- patient-care relevance across specialties
The paper does not need a deep mechanistic story if the clinical question is broad enough.
In Our Pre-Submission Review Work
In our pre-submission review work, Nature Medicine vs JAMA decisions usually fail because authors choose the more prestigious-sounding fit rather than the reader fit.
Translational paper aimed at JAMA: the clinical condition matters, but the manuscript's real contribution is mechanism, biomarker biology, or technology. JAMA readers may see a paper that takes too long to reach a practice consequence.
Clinical paper aimed at Nature Medicine: the result matters for patients or systems, but the mechanistic bridge is thin. Nature Medicine editors may see an excellent clinical paper that belongs in a clinical journal.
Metric-first targeting: authors compare JIF and ignore the first page. That is the wrong decision rule.
Nature Medicine Failure Patterns
Nature Medicine gets harder when:
- the human dataset is small or decorative
- the clinical result is practice-facing but not mechanistic
- the translational bridge appears late
- the paper feels like a clinical trial with a thin biomarker add-on
- the first figure does not show why human biology is changing
The manuscript has to look designed for a translational audience from the beginning.
JAMA Failure Patterns
JAMA gets harder when:
- the best audience is a narrow specialty community
- the main result requires technical biology before the clinical meaning appears
- the evidence is interesting but not broadly useful
- the abstract overstates clinical actionability
- the paper is really a Nature Medicine-style mechanistic bridge
JAMA fit is not just "medical topic." It is broad clinical relevance.
Practical Targeting Matrix
Manuscript pattern | Better target |
|---|---|
Phase 1 trial with deep biomarker mechanism | Nature Medicine |
Pragmatic clinical trial with broad practice relevance | JAMA |
Pan-disease biomarker biology | Nature Medicine |
Health-system intervention study | JAMA |
AI model revealing disease biology | Nature Medicine |
AI model improving clinical workflow or diagnosis | JAMA or JAMA specialty journal |
Public health study with practice relevance | JAMA |
Hybrid preclinical and clinical package | Nature Medicine |
The question is not "which journal is better?" It is "which editor sees the manuscript's value fastest?"
What To Fix Before Submission
For Nature Medicine, make the mechanism-to-human bridge visible in the title, abstract, first figure, and cover letter. The clinical data should not feel like a final validation panel added to a basic science paper.
For JAMA, make the clinical consequence visible in the title, structured abstract, and first table or figure. The reader should not need to understand every molecular detail to see why the result matters.
Submit If / Think Twice If
Submit to Nature Medicine if:
- the manuscript has a real translational bridge
- human relevance is demonstrated, not decorative
- the strongest audience includes translational scientists
- clinical data and biology support one argument
Submit to JAMA if:
- the manuscript matters to a broad clinical audience
- the result is readable and practice-facing
- reporting and study design are already clean
- the paper does not need a mechanistic explanation to matter
Think twice for both if:
- the paper is mainly a specialty result
- the first page cannot name the audience
- the target is chosen by impact factor alone
Bottom Line
Nature Medicine and JAMA are close enough in metric prestige that the decision should be editorial. Nature Medicine wants translational mechanism with human relevance. JAMA wants broad clinical evidence a medical audience can use.
Use the AI manuscript review if you need a fast read on which journal your first page actually supports.
Frequently asked questions
Submit to Nature Medicine when the strongest story is translational mechanism with human relevance. Submit to JAMA when the strongest story is broad clinical evidence, health policy, or practice-relevant medicine.
JAMA is commonly cited at a 2024 JCR impact factor of 55.0, while Nature Medicine reports a 2024 JIF of 50.0. The difference should not decide journal fit.
Yes, if the clinical trial carries mechanistic, biomarker, or translational insight. A trial whose main value is practice evidence is usually a better fit for JAMA or another clinical journal.
The two pages would answer the same comparison query. Manusights uses one canonical comparison page to avoid cannibalization.
Sources
- https://www.nature.com/nm/aims
- https://www.nature.com/nm/journal-impact
- https://jamanetwork.com/journals/jama/pages/for-authors
- https://jamanetwork.com/journals/jama/pages/instructions-for-authors
- https://jcr.clarivate.com/
Final step
See whether this paper fits Nature Medicine.
Run the Free Readiness Scan with Nature Medicine as your target journal and get a manuscript-specific fit signal before you commit.
Anthropic Privacy Partner. Zero-retention manuscript processing.
Where to go next
Start here
Same journal, next question
Compare alternatives
Supporting reads
Conversion step
See whether this paper fits Nature Medicine.
Anthropic Privacy Partner. Zero-retention manuscript processing.